Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.
Radiation therapy aims to kill cancer cells with a minimum of normal tissue toxicity. Dying cancer cells have been proposed to be a source of tumor antigens and may release endogenous immune adjuvants into the tumor environment. For these reasons, radiation therapy may be an effective modality to in...
Main Authors: | Marka R Crittenden, Benjamin Cottam, Talicia Savage, Cynthia Nguyen, Pippa Newell, Michael J Gough |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22761754/pdf/?tool=EBI |
Similar Items
-
The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.
by: Marka R Crittenden, et al.
Published: (2013-01-01) -
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.
by: Kristina H Young, et al.
Published: (2016-01-01) -
The paradox of radiation and T cells in tumors
by: Michael J. Gough, et al.
Published: (2022-09-01) -
Defining Immunogenic and Radioimmunogenic Tumors
by: Terry R. Medler, et al.
Published: (2021-03-01) -
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
by: Hari Menon, et al.
Published: (2019-02-01)